ZSHK’s pharmacodynamics team is an important part of the company's preclinical research
Composed of PhDs and masters with 10 to 20 years of experience in new drug R&D and evaluation as the core, the team functions based on diverse professional backgrounds covering medicine, toxicology, pharmacology, molecular biology, physiology, pathology, medical immunology, etc. As experience accumulates through long-time practicing, the team has established a complete animal model library, which can provide various effective animal models according to the needs of customers for early drugability evaluation and preclinical research for IND application.
Fluorescence quantitative PCR instrument
Multifunctional Microplate Reader
Gel Electrophoresis System & Imaging System
Inverted Fluorescence Microscope
◆ Anti-tumor drug-related experiments: establishment and efficacy evaluation of various CDX xenograft animal models
◆ Respiratory system diseases: pulmonary fibrosis, pulmonary embolism, asthma, COPD, etc.
◆ Metabolic system diseases: diabetes, fatty liver, animal models of liver fibrosis, obesity, hyperuricemia, atherosclerosis, etc.
◆ Nervous system experiments: pain models, etc.
◆ Immune system diseases: establishment and efficacy evaluation of psoriasis animal models and ulcerative colitis models
◆ Urinary system diseases: drug-induced renal impairment, surgery-induced renal impairment, renal insufficiency, renal failure, etc.
◆ Other types: diabetic foot model, premature ovarian failure model, etc.